Unilever Consumer Care Ltd

The company maintains a debt-to-equity ratio of 0.31, indicating a relatively conservative capital structure with limited leverage. Its current ratio of 1.93 suggests adequate short-term liquidity to cover current liabilities, though free cash flow of 92.66 million BDT is modest relative to operating cash flow of 493.78 million BDT. Profitability metrics show a return on equity (ROE) of 27.29% and return on assets (ROA) of 13.57%, both exceeding the typical thresholds for the Food Processing industry, which emphasizes margin efficiency and asset utilization. Operating income of 666.91 million BDT and net income of 667.21 million BDT reflect strong gross margin performance, with a gross profit of 1.43 billion BDT on 3.38 billion BDT in revenue. The company operates as a single business segment, with all revenue derived from consumer healthcare products in Bangladesh. There is no disclosed geographic diversification, and the revenue concentration in a single market increases exposure to local economic and regulatory risks. Revenue growth in the latest period was 1.17% year-over-year, with actual revenue of 3.38 billion BDT compared to an analyst estimate of 3.42 billion BDT. While the company has maintained consistent revenue and profit levels, there is no indication of significant acceleration in growth or expansion into new markets. Risk factors include a medium liquidity rating and a negative net cash position after subtracting total debt, which could constrain flexibility in capital allocation or response to market shocks. Dilution risk is assessed as low, with no recent or disclosed share issuance activity and no material dilution adjustments in the valuation model. Recent filings and transcripts do not include material events or strategic announcements. The company’s operations remain focused on maintaining market share in the consumer healthcare segment in Bangladesh, with no disclosed R&D or innovation initiatives in the latest financial data.